# Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study

> **NCT01248754** · PHASE2 · COMPLETED · sponsor: **Alan Nichol** · enrollment: 20 (actual)

## Conditions studied

- Cancer (High-grace Glioma)

## Interventions

- **PROCEDURE:** Surgical neuronavigation with 18F-DOPA PET imaging

## Key facts

- **NCT ID:** NCT01248754
- **Lead sponsor:** Alan Nichol
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01248754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01248754, "Positron Emission Tomography (PET) With 3,4-dihydroxy-6-18F-fluoro-L-enylalanine (18F-FDOPA) Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01248754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*